Samad MA, Mahboob E, Mansoor H. Chronic myeloid leukemia: a type of MPN.
Blood Res 2022;
57:95-100. [PMID:
35620905 PMCID:
PMC9242828 DOI:
10.5045/br.2022.2021173]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2021] [Revised: 01/15/2022] [Accepted: 03/07/2022] [Indexed: 11/17/2022] Open
Abstract
This review article classifies chronic myeloid leukemia (CML) based on cytogenetic analyses and different mutations detected in CML patients. The use of advanced technologies, such as karyotyping, fluorescent in situ hybridization, and comparative genomic hybridization, has allowed us to study CML in detail and observe the different biochemical changes that occur in different CML types. This review also highlights the different types of receptor and signaling pathway mutations that occur in CML.
Collapse